• DEVENEZ MEMBRE
    Pour un accès complet à theheart.org
    À titre de membre permanent, vous pourrez accéder au contenu éditorial et de formation continue, utiliser le moteur de recherche, recevoir nos newsletters, participer aux discussions, télécharger des diapositives et plus encore.

    L'abonnement est gratuit !
    Inscrivez-vous maintenant !
    Obtenez un accès limité de 30 jours aux articles de heartwire
    Professionnel de la santé   Oui Non
    Obtenez un accès limité !

ASHem 2011 - San Diego, CA

Heartwire

Thrombosis
RECOVER II confirms benefit of dabigatran in treatment of VTE
Dec 19, 2011 16:45 EST
The new study adds another 2500 patients tested with dabigatran in the setting of VTE, confirming the results observed in the first RECOVER study.
Support for edoxaban for VTE prevention
Thrombosis
Support for edoxaban for VTE prevention
Dec 19, 2011 13:00 EST
The benefit of edoxaban over enoxaparin for the prevention of VTE following hip and knee surgery did not appear to come at a cost, according to investigators, as there was no statistically significant increased risk in bleeding in the overall cohort or in any subgroups.
Catheter-directed thrombolysis in iliofemoral DVT reduces risk of postthrombotic syndrome
Thrombosis
Catheter-directed thrombolysis in iliofemoral DVT reduces risk of postthrombotic syndrome
Dec 13, 2011 15:15 EST
Catheter-directed thrombolysis significantly reduced the risk of postthrombotic syndrome at 24 months and increased venous patency after six months, compared with standard therapy in patients with a high proximal deep vein thrombosis, according to the results of a new study. There were 20 bleeding events associated with thrombolysis, although investigators expect these event rates to decline.
Less than 10% of retrievable IVC filters removed, even though indication no longer present
Thrombosis
Less than 10% of retrievable IVC filters removed, even though indication no longer present
Dec 13, 2011 07:45 EST
At one large US trauma center, less than 10% of inferior vena cava filters are removed from patients, despite the fact that the initial indication for the filter is no longer present. In addition, 18% of filters could not be removed for various reasons, making this an underrecognized problem, say researchers.
Thrombosis
Bleeding risk scores provide mixed results, especially in intermediate-risk patients
1 COMMENT - Dec 12, 2011 15:00 EST
Overall, the bleeding risk scores were able to identify patients at high risk for bleeding but had limited ability to identify patients at intermediate risk, report investigators.
Thrombosis
Aspirin a safe, low-cost option for preventing recurrent VTE after anticoagulation stopped
2 COMMENTS - Dec 12, 2011 09:30 EST
Investigators say the reduction in recurrent VTE risk, which was achieved without an increased risk of bleeding, makes aspirin an attractive treatment option for the extended prevention of recurrent VTE once oral anticoagulation is stopped.

Discussion and opinions

Blogs
This week in cardiology from heartwire
#121: Vitamin D fails again to affect CV mortality; more overstenting charges in Maryland; data...
Dec 23, 2011 11:45 EST